Gary Fischer Email & Phone Number

Thompson's Station, TN, US

• Improved client’s ability to forecast, report, and consolidate their businesses through upgraded financial modeling, data analysis, and systems integration.

Irvine, California, US

• $15M angel backed start-up chain of 15 non invasive medical aesthetic treatment shops across 4 states growing nearly 100% CAGR since inception.
• Oversaw due diligence to integration of 2 acquisitions that doubled the # of centers; taking us from $7M to $14M annualized revenue.
• Implemented quarterly P&L model tied to cash flow that drove forecasting time down over 90%.
• Led the legal entity reorganization and accounting process change that simplified month end close, driving it to 10 days from 3 months.
• Implemented new ERP, HRIS, and cap table management systems while refinancing equipment leases that streamlined operations and decreased costs by $500k annually.
• Established new KPI metrics and tracking to increase management and board visibility to our numbers

Orange, California, US

• $315M China-based family owned / private equity backed U.S. consumer packaged goods manufacturing company. Responsible for financial reporting, planning / budgeting, AP / AR, banking and operations / process.
• Led the 5 year strategic plan, annual budgeting, and monthly forecasting and reporting process; partner with sales and marketing leaders, business controller, and cost accounting managers.
• Drove gross margin improvements through sourcing recommendations; worked with the VP, procurement to drive efficiencies in our supply chain, in China, Indonesia and in the U.S..
• Supported the sales, marketing and product development efforts to profitably grow existing customers and expand the company’s sales channels.

Newport Beach, California, US

• Venture capital and physician funded healthcare technology start-up company. Helped grow revenue from $65M to $120M by completion of 4 deals. Responsible for pre deal analysis to post deal integration. Reported to the.
• Analyzed prospective acquiree P&L’s, balance sheets, and recent sales performance to advise senior management on proposed deal structures and purchase prices.
• Managed the M&A strategic 5 year plan; forecasted ALPHAEON's cash forecast to accurately reflect acquiree operating cash burn, future deal obligations, and estimated performance.
• Instituted new cash flow and A/P guidelines that decreased post-deal cash burn by 70% while prioritizing payment to the largest vendor who represented 70% of outstanding A/P.
• Developed ALPHAEON’s acquisition model.

Dublin, Coolock, IE

• $7B global, specialty pharmaceutical company. Financial responsibility for the U.S. Botox® Therapeutic business ($1B sales, $300M expenses, $600M operating income) growing 20% per annum. Reported to the VP, Finance /.
• Led the FP&A business partnership and decision support agenda working closely with sales and operating leaders and other senior management; analyzed state of business, risks and opportunities to grow the business.
• Drove the quarterly forecast and annual budgeting process; developed market models, analyzed risks / opportunities, and worked with corporate planning to communicate drivers of business.

Dublin, Coolock, IE

• Responsible for 15 global financial operations audits annually. Led staff of 5 in a hands-on environment. Reported to the VP, Finance and Chief Audit Officer.
• Spearheaded the corporate mindset shift that internal audit is a value added business partner.
• Effectively recruited, trained, retained, and provided leadership to a new financial operations audit team that had experienced 100% turnover the prior year due to multiple promotions.

Dublin, Coolock, IE

• Responsible for the U.S. Facial Aesthetics business ($750M sales, $200M expenses, $300M operating income) growing 10% per annum. Supervised month end close. Led one Finance Manager. Reported to the VP, Finance /.
• Improved the business’s ability to anticipate positive / negative variances; managed the quarterly “landing” process to +/- 0.1% accuracy on a $100M bottom line to ensure the company hit committed Wall Street estimates.
• Drove the commercial strategic planning process; developed models and volume / rate / mix analyses that fed the corporate strategic plan.
• Developed, prepared and presented the monthly operational and financial metrics deck to Facial Aesthetics management; deck was used as a reference by the CEO in earnings calls.
• Key member of the Longview, a business performance management tool, implementation team.

Dublin, Coolock, IE

• Responsible for financial planning, analysis, and reporting for the U.S. Health and Breast Aesthetics businesses ($400M sales, $80M expenses), growing 50% and 10% per annum, respectively. Led staff of two (Finance.
• Key member on the $3.2B acquisition of Inamed; oversaw the system transition from Oracle to SAP, decreased the time to create a report by 85%, and improved the accuracy of another by 80%.
• Performed month end close and reconciled multiple balance sheet accounts.

Chicago, Illinois, US

$15B consumer packaged goods company. Led 1 Finance Manager. Company relocated to Chicago.

Chicago, Illinois, US

Led FP&A on the $600M Special Markets business consisting of >100 brands across 3 channels.

Chicago, Illinois, US

Responsible for month end reporting, variance and ad hoc analyses on $200M across three brands.

North Reading, MA, US

$3B global semiconductor capital test equipment company.

Mba, Finance

Bs, Biology